NO20041315L - Medikamentavleveringssystem - Google Patents

Medikamentavleveringssystem

Info

Publication number
NO20041315L
NO20041315L NO20041315A NO20041315A NO20041315L NO 20041315 L NO20041315 L NO 20041315L NO 20041315 A NO20041315 A NO 20041315A NO 20041315 A NO20041315 A NO 20041315A NO 20041315 L NO20041315 L NO 20041315L
Authority
NO
Norway
Prior art keywords
delivery system
drug delivery
drug
delivery
Prior art date
Application number
NO20041315A
Other languages
English (en)
Inventor
Juha Ala-Sorvari
Manja Ahola
Timo Haapakumpu
Marko Aaltonen
Antti Keinanen
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Oy filed Critical Schering Oy
Publication of NO20041315L publication Critical patent/NO20041315L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20041315A 2001-08-31 2004-03-30 Medikamentavleveringssystem NO20041315L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31597201P 2001-08-31 2001-08-31
PCT/FI2002/000692 WO2003017971A1 (en) 2001-08-31 2002-08-27 Drug delivery system

Publications (1)

Publication Number Publication Date
NO20041315L true NO20041315L (no) 2004-03-30

Family

ID=23226904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041315A NO20041315L (no) 2001-08-31 2004-03-30 Medikamentavleveringssystem

Country Status (14)

Country Link
US (1) US20040247674A1 (no)
EP (1) EP1427390A1 (no)
JP (1) JP2005503389A (no)
KR (1) KR20040036928A (no)
CN (1) CN1289064C (no)
AR (1) AR036310A1 (no)
AU (1) AU2002313517B2 (no)
CA (1) CA2457979A1 (no)
HU (1) HUP0401438A3 (no)
NO (1) NO20041315L (no)
PE (1) PE20030316A1 (no)
PL (1) PL367961A1 (no)
RU (1) RU2302883C2 (no)
WO (1) WO2003017971A1 (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US20040181943A1 (en) * 2003-03-18 2004-09-23 Michael Kwiecien Shaving systems
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
EP1508343B1 (en) * 2003-08-21 2015-11-04 AddBIO AB Bisphosponate coated implant device and method therefor
EP1906941A4 (en) * 2004-06-22 2011-08-10 Greystone Medical Group Inc METHOD FOR TREATING WOUNDS COMPRISING DELAYED RELEASE COMPOSITIONS
EP1629844B2 (en) * 2004-07-13 2012-04-18 Bayer Schering Pharma Oy A longterm delivery system with controlled initial burst
US7494665B1 (en) 2004-07-30 2009-02-24 Advanced Cardiovascular Systems, Inc. Polymers containing siloxane monomers
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2007109247A2 (en) * 2006-03-20 2007-09-27 Duramed Pharmaceuticals, Inc. Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
RU2342125C1 (ru) * 2007-04-27 2008-12-27 Александр Сергеевич Бабиков Способ введения анестетика в ткани
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
EP2057972A1 (en) * 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit
PT2062569E (pt) * 2007-11-22 2011-07-25 Bayer Oy Sistema de administração vaginal
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
ES2648640T3 (es) * 2008-02-04 2018-01-04 Ferring B.V. Anillos intravaginales monolíticos que comprenden progesterona y métodos de fabricación y usos de los mismos
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
RU2494706C2 (ru) 2008-09-17 2013-10-10 Байер Ой Устройство для введения
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
PL2381932T3 (pl) * 2009-01-29 2019-01-31 Fondazione Irccs Istituto Nazionale Dei Tumori Urządzenie wewnątrzszyjkowe do uwalniania leków w miejscowo- regionalnym leczeniu nowotworu szyjki macicy
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102525722A (zh) * 2010-12-30 2012-07-04 辽宁爱母医疗科技有限公司 具有记忆效应的智能型复方孕二烯酮阴道环制剂及其应用
EP2476409A1 (en) * 2011-01-14 2012-07-18 Université Catholique De Louvain Implant comprising a core and a tube encasing the core
DE202012012761U1 (de) * 2011-04-07 2013-10-29 Arstat, Inc. Mit Arzneimittel versehene intravaginale Vorrichtung und pharmazeutische Zusammensetzung zur Behandlung von Menstruationsschmerzen und übermäßigem Menstruationsblutverlust
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
DE102012024126A1 (de) 2011-12-20 2013-06-20 Merck Patent Gmbh Flüssigkristallines Medium
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
US10154856B2 (en) 2013-02-06 2018-12-18 Mark SILLENDER Therapeutic substance transfer catheter and method
US10188426B2 (en) 2013-02-06 2019-01-29 Mark SILLENDER Embryo transfer catheter and method
SE539540C2 (sv) * 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
US9963556B2 (en) 2013-09-18 2018-05-08 Senseonics, Incorporated Critical point drying of hydrogels in analyte sensors
TN2016000134A1 (en) * 2013-10-18 2017-10-06 Bayer Oy Intrauterine delivery system.
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10772842B2 (en) * 2015-01-09 2020-09-15 Patheon Softgels Inc. Abuse-deterrent opioids
BR112016025045A2 (pt) * 2014-05-30 2017-08-15 Textile Based Delivery Inc sistema de distribuição de fármaco e método de distribuição de um composto biologicamente ativo
PT3247327T (pt) 2015-01-21 2019-10-24 Bayer Oy Sistema de entrega de fármaco que compreende um antiinflamatório não esteroide (nsaid) e um composto progestogénico, bem como métodos para produção.
WO2016180764A1 (en) 2015-05-13 2016-11-17 Bayer Oy A long acting drug delivery device and its use in contraception
CN105056376A (zh) * 2015-08-21 2015-11-18 崔尚品 一种治疗宫颈炎和宫颈hpv感染的医疗器械
WO2019094625A1 (en) * 2017-11-09 2019-05-16 Nexien Biopharma, Inc. Methods and compositions for parenteral administration of cannabidiol in the treatment of convulsive disorders
CN111770750B (zh) * 2017-12-22 2024-05-10 阿利拉生物科技有限公司 痛经有关的疼痛和/或疼痛相关症状的治疗
CN110917478B (zh) * 2019-12-10 2020-11-24 河南省肿瘤医院 一种宫颈hpv感染用药物缓释器
US11338119B2 (en) * 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) * 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
CA3171976A1 (en) 2020-03-20 2021-09-23 Carlos Schuler Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) * 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
WO2022029780A1 (en) * 2020-08-06 2022-02-10 Bless Medical Ltd. Intrauterine device for controlled drug release
US20230047191A1 (en) * 2021-08-05 2023-02-16 Celanese Eva Performance Polymers Llc Implantable Medical Device for the Delivery of Bisphosphonate

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL133105A (en) * 1997-06-04 2004-09-27 Debio Rech Pharma Sa Implants for controlled release of pharmaceutically active principles and method for making same
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females

Also Published As

Publication number Publication date
HUP0401438A2 (hu) 2004-11-29
RU2004109575A (ru) 2005-08-20
CN1549703A (zh) 2004-11-24
PL367961A1 (en) 2005-03-07
AR036310A1 (es) 2004-08-25
JP2005503389A (ja) 2005-02-03
WO2003017971A1 (en) 2003-03-06
CA2457979A1 (en) 2003-03-06
EP1427390A1 (en) 2004-06-16
PE20030316A1 (es) 2003-04-03
HUP0401438A3 (en) 2008-04-28
CN1289064C (zh) 2006-12-13
AU2002313517B2 (en) 2007-09-06
US20040247674A1 (en) 2004-12-09
KR20040036928A (ko) 2004-05-03
RU2302883C2 (ru) 2007-07-20

Similar Documents

Publication Publication Date Title
ATE405630T1 (de) Wirkstoffabgabesysteme
DE60016271D1 (de) Medikamentenzuführvorrichtung
HUP0401438A3 (en) Drug delivery system
EP1379291A4 (en) Integrated medication delivery system
DK1545662T3 (da) Lægemiddelindgivelsessystem
ATE526973T1 (de) Verbesserte arzneimittelabgabe in transdermalen systemen
DK1409065T3 (da) Oftalmisk medikamentafgivelsesanordning
NO20004196L (no) Innretninger for legemiddelavlevering
SI1631255T1 (sl) Sistem za razdeljevanje zdravil
ATE381262T1 (de) Pestizid-abgabesystem
EE200300416A (et) Ravimvorm
PL376169A1 (en) Drug delivery system
DE60217615D1 (de) Inhaltlieferungssystem
NO20024194L (no) Nytt selvemulgerende legemiddelavleveringssystem
NO20035315D0 (no) Farmasöytiske kombinasjoner
DE50209245D1 (de) Neuroprotektives medikament
ATE322161T1 (de) Stoffabgabevorrichtung
GB0103877D0 (en) Novel Drug Delivery system
DE10192797D2 (de) Drug-Delivery-Systeme
FR2820311B3 (fr) Distributeur de medicament portatif
DK1183061T3 (da) Lægemiddelafgivelsessystem
GB0115136D0 (en) Drug delivery system
GB0112326D0 (en) Drug delivery system
ITMO20010236A0 (it) Mezzi erogatori
DK1330280T3 (da) Lægemiddelinhalator

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application